Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-003320
Filing Date
2024-01-09
Accepted
2024-01-09 15:58:18
Documents
74
Period of Report
2023-11-30

Document Format Files

Seq Description Document Type Size
1 10-Q neog-20231130.htm   iXBRL 10-Q 2240179
2 EX-31.1 neog-ex31_1.htm EX-31.1 13632
3 EX-31.2 neog-ex31_2.htm EX-31.2 13447
4 EX-32 neog-ex32.htm EX-32 10976
  Complete submission text file 0000950170-24-003320.txt   10060275

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT neog-20231130.xsd EX-101.SCH 1630648
68 EXTRACTED XBRL INSTANCE DOCUMENT neog-20231130_htm.xml XML 1844881
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Filer) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: 10-Q | Act: 34 | File No.: 000-17988 | Film No.: 24523199
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)